Lab studies confirm Betadine’s® effectiveness against Covid-19 virus



Singapore – Mundipharma today (July 10) announced that laboratory testing at the Duke-NUS Medical School in Singapore, has confirmed the effectiveness of its Betadine® antiseptic products against the novel coronavirus (SARS-CoV-2) which causes Covid-19 disease.

Testing has demonstrated Betadine’s® strong in-vitro virucidal activity, killing 99.99% of the SARS-CoV-2 virus in 30 seconds. The products subjected to testing were: Betadine® antiseptic products, namely Solution (10% PVP-I), Skin Cleanser (7.5% PVP-I), Gargle and Mouthwash (1.0% PVP-I) and Throat Spray (0.45% PVP-I).

The research has been published in the respected Infectious Disease and Therapy Journal on  July 8, 2020.

“These results confirm our view that Betadine® antiseptic products, used appropriately and in conjunction with other preventative treatment options including PPE, can play a role in limiting the spread of infections, including Covid-19,” said Raman Singh, CEO Mundipharma.

“It also provides the medical community as well as consumers with a science-based assurance that they are using a product that is a proven defence against Covid-19,” he added.

The study conducted at Duke-NUS is complemented by Laboratory testing completed at the Tropical Infectious Diseases Research and Education Centre (TIDREC) at the University of Malaya, Malaysia, that also demonstrated strong in-vitro virucidal activity, with the tested product Betadine® Gargle and Mouthwash (1.0% PVP-I) killing 99.99% of the SARS-CoV-2 virus in 15 seconds. The TIDREC research has been accepted by the British Dental Journal (BDJ) and was published as a Letter on June 26, 2020. The journal is published by Springer Nature on behalf of the British Dental Association.

Previously, Betadine® antiseptic products containing povidone iodine (PVP-I) have been proven effective in vitro against a wide range of viruses, including coronaviruses that have caused major outbreaks such as Middle East Respiratory Syndrome (MERS) and Severe Acute Respiratory Syndrome (SARS). The Betadine® antiseptic range containing povidone-iodine (PVP-I) is also highly effective against a wide range of other microorganisms, including bacteria, viruses and fungi and is typically used in hospitals.


Top: Small bottles of Betadine antiseptic solution. Photo:




TNR staff
I am veteran journalist and part of’s editorial team. We are working hard at making this news site a success and value the support of each and every reader

Leave a Reply